Global Anticoccidial Drugs Market is expected to have a growth rate of 3.61% CAGR from 2018 to 2024 to reach a market size of USD 1511 Million by 2024 end, as per the market research analysts at Market Data Forecast.
The major driving factor for the anticoccidial drugs market is increasing the consumption rate of meat and poultry products. In addition, growing incidences of infectious diseases among animals are accelerating the demand of the market. Rising demand to improve the quality of the poultry products across the world is propelling the growth of the Anticoccidial Drugs Market.
However, lack of sufficient knowledge over the utilization of drugs dosage forms in many areas is hindering the demand of the market. The volatility of raw materials is fluctuating the prices of the end products and this remained a challenging factor for the market. Availability of other drugs is slightly to hamper the demand of the Anticoccidial Drugs Market.
Increasing prevalence to improve the production rate of the drugs with high quality is solely to surge growth opportunities for the market. Also, growing support from the government through investments in the pharmaceutical industries is boosting up the demand of the Anticoccidial Drugs Market.
|
Report Metric |
Details |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 – 2024 |
|
Segments Analysed |
By Drug Type, Animal Type and Region |
|
Regions Analysed |
North America (United States and Canada), Europe (UK, Spain, Germany, Italy, France and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Argentina, Mexico and Rest of Latin America), Middle East and Africa |
|
Companies Analysed |
Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc. |
On the basis of drug type, the market is segmented into Antibiotic anticoccidials, ionophore anticoccidial, and chemical derivative anticoccidial. Ionophore anticoccidial drug type witnessed the highest shares of the market. Increasing research and development institutes in order to launch a number of various drugs are leveraging the demand of the market.
On the basis of animal, the market divisions are poultry, swine, fish, cattle and companion animals. The poultry segment is holding largest shares of the market. The rise in the expenditure on healthcare is also an additional attribute for the market to grow eventually.
Regionally, the global anticoccidial drugs market is segmented into Asia Pacific, North America, Europe, the Middle East, and Africa. North America is ruling with the highest shares of the market by owing to the adoption of advanced techniques in manufacturing drugs. Also, the launch of innovative drugs which are in favor to produce highest quality products is greatly influencing the demand of the Anticoccidial Drugs Market.
Asia pacific is following North America in holding dominant shares of the market with the rising population and growing demand for poultry products. In addition to this, the market is also fueled by the increasing scale of the pharmaceutical industries across the region.
Europe will be growing at a faster rate in foreseen years with the growing consumption rate of the meat.
The Middle East and Africa are deemed to have prominent growth rate in coming years.
Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc. are few of the promising companies in the Global Anticoccidial Drugs Market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Drug Type
5.1.1 Antibiotic anticoccidials
5.1.2 Ionophore anticoccidials
5.1.3 Chemical derivative anticoccidials
5.2 By Animal Type
5.2.1 Poultry
5.2.2 Swine
5.2.3 Fish
5.2.4 Cattle
5.2.5 Companion Animal
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bayer Health care
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Zoetis
8.3 Elanco
8.4 Merck Animal Healthcare
8.5 Virbac
8.6 Ceva Santé Animale
8.7 Boehringer Ingelheim Animal Health
8.8 Novartis Animal Healthcare
8.9 Smartvet Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a.List of Tables
b.List of Figures
Related Reports
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
